First Warning Systems Inc, a life sciences software and medical device company, has retained Joshua D. I. Ellenhorn, MD, as its principal investigator (PI) in preparation for the anticipated clinical validation studies slated for later this year.
FWS is working toward the realization of its non-invasive, intelligent, wearable, biofeedback early breast cancer screening device. Retention of an expert PI is a step toward bringing the product and service to market in the near term.
Ellenhorn has worked in breast cancer treatment for years. In addition to being clinical professor of surgery at Cedars-Sinai Medical Center and adjunct professor at the John Wayne Cancer Center, Ellenhorn has directed extensive laboratory research to develop new cancer vaccines that work on the immune system to identify and eliminate cancer cells. A medical educator, Ellenhorn has trained more than 60 surgical oncologists.
